Report of Foreign Issuer (6-k)
April 29 2020 - 2:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
April 29, 2020
Commission File Number 001-39059
AVITA MEDICAL LIMITED
(Name of Registrant)
Level 7,
330 Collins Street
Melbourne VIC 3000 Australia
Tel: +61 (0) 3 8689 9997
Fax: +61 (0) 8 9474 7742
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ☐ No ☒
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- .
AVITA MEDICAL LIMITED
Form 6-K
TABLE OF CONTENTS
|
|
|
|
|
Page
|
Explanatory Note
|
|
Page 2
|
|
|
Signatures
|
|
Page 3
|
|
|
Avita Medical Reports Third Quarter Fiscal 2020 Financial Results and Company Update
|
|
Exhibit 99.1
|
EXPLANATORY NOTE
Avita Medical Limited (the Company) published its Third Quarter Fiscal 2020 Financial Results and Company Update (the Public Notice)
to the Australian Securities Exchange on April 29, 2020. A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.
This report on Form 6-K (including the exhibit hereto) shall not be deemed to be filed for purposes of the
Securities Exchange Act of 1934, as amended (the Exchange Act) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such
filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
Avita Medical Limited
|
|
|
By:
|
|
/s/ David McIntyre
|
Name:
|
|
David McIntyre
|
Title:
|
|
Chief Financial Officer
|
Date: April 29, 2020
3
Avita Medical (NASDAQ:RCEL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avita Medical (NASDAQ:RCEL)
Historical Stock Chart
From Sep 2023 to Sep 2024